TY - JOUR A1 - Reger, Guido A1 - Adelhelm, Silvia A1 - Braun, Andreas T1 - Lead User : von der Kundenorientierung zur Kundenintegration Y1 - 2009 SN - 978-3-428-13238-6 ER - TY - JOUR A1 - Braun, Andreas A1 - Reger, Guido T1 - Innovation, science and institutional change : a research handbook Y1 - 2009 UR - http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291467-9310 U6 - https://doi.org/10.1111/j.1467-9310.2008.00543_1.x SN - 0033-6807 ER - TY - THES A1 - Braun, Andreas T1 - Open innovation - an analysis of the individual level Y1 - 2014 CY - Potsdam ER - TY - JOUR A1 - Braun, Andreas A1 - Bockelmann, Laura T1 - An individual perspective on open innovation capabilities in the context of haute cuisine JF - International journal of innovation in management N2 - Previous research on open innovation (OI) has primarily focused on the organisational level of R&D intensive industries. With this paper, we contribute to research on the individual level of analysis by analysing specific perspectives in the context of creative industries. Our study is based on 36 interviews with Haute cuisine chefs in France, Germany, Great Britain, Italy, Spain, Sweden, and Switzerland listed in the 2012 Michelin Guide. Building on the OI capability concept, our results demonstrate that chefs use absorptive and desorptive capacity (AC, DC) as means to generate and market culinary innovations, respectively. Moreover, we found that chefs almost exclusively rely on their own inventive and innovative capabilities in the early stages of the culinary innovation process. In subsequent phases, however, chefs increasingly integrate other sources such as employees, suppliers, and guests. Our study contributes to the literature in two ways. First, we research the individual level within the OI process, and second, we provide insight into OI practices in the creative industries. KW - Open innovation KW - open innovation capabilities KW - Haute cuisine KW - creative industries Y1 - 2016 U6 - https://doi.org/10.1142/S136391961650002X SN - 1363-9196 SN - 1757-5877 VL - 20 SP - 480 EP - 499 PB - World Scientific CY - Singapore ER - TY - JOUR A1 - Ullrich, André A1 - Vladova, Gergana A1 - Marquart, Danny A1 - Braun, Andreas A1 - Gronau, Norbert T1 - An overwiew of benefits and risks in open innovation projects and the influence of intermediary participation, decision-making authority, experience, and position on their perception JF - International journal of innovation management : IJIM N2 - This paper presents an exploratory study investigating the influence of the factors (1) intermediary participation, (2) decision-making authority, (3) position in the enterprise, and (4) experience in open innovation on the perception and assessment of the benefits and risks expected from participating in open innovation projects. For this purpose, an online survey was conducted in Germany, Austria and Switzerland. The result of this paper is an empirical evidence showing whether and how these factors affect the perception of potential benefits and risks expected within the context of open innovation project participation. Furthermore, the identified effects are discussed against the theory. Existing theory regarding the benefits and risks of open innovation is expanded by (1) finding that they are perceived mostly independently of the factors, (2) confirming the practical relevance of benefits and risks, and (3) enabling a finer distinction between their degrees of relevance according to respective contextual specifics. KW - Open innovation KW - intermediaries KW - benefits KW - decision-making KW - experience; KW - risks Y1 - 2022 U6 - https://doi.org/10.1142/S1363919622500128 SN - 1363-9196 SN - 1757-5877 VL - 26 IS - 02 PB - World Scientific Publ. CY - Singapore ER - TY - JOUR A1 - Adelhelm, Silvia A1 - Braun, Andreas A1 - Gronau, Norbert A1 - Lürig, Detlef A1 - Müller, Elisabeth A1 - Vladova, Gergana A1 - Wagner, Dieter T1 - Mit Open Innovation zum Erfolg BT - So verbessern mittelständische Pharmaunternehmen ihre Innovationsprozesse JF - Handbuch prozessorientiertes Wissensmanagment Y1 - 2014 SN - 978-3-95545-026-7 SP - 211 EP - 226 PB - GITO CY - Berlin ER - TY - BOOK A1 - Adelhelm, Silvia A1 - Braun, Andreas A1 - Gronau, Norbert A1 - Müller, E. A1 - Vladova, Gergana T1 - Open Innovation : Methodologische Präzisierung und praktische Umsetzung im Projekt Open Innovation in Life Sciences Y1 - 2010 SN - 978-3-8396-0141-9 ER - TY - BOOK A1 - Adelhelm, Silvia A1 - Braun, Andreas A1 - Müller, Elisabeth A1 - Vladova, Gergana T1 - Philo : PharmaInnovationsLotse ; ihr Weg zum erfolgreichen Open Innovation Management N2 - Vorliegender Leitfaden ist eines der Ergebnisse des Forschungsprojekts „Open Innovation in Life Sciences“ (OIL), das von Mai 2008 bis April 2011 an der Universität Potsdam durchgeführt wurde. Er nimmt für sich in Anspruch, gerade Innovationsmanager in kleinen und mittleren Unternehmen (KMU) der Pharmaindustrie bei der Einführung des Open Innovation Managements zu unterstützen. Zielsetzung des Forschungsprojekts war es, (1) die Chancen und Risiken von Open Innovation unter besonderer Berücksichtigung der Anforderungen von Pharma-KMU zu analysieren und (2) daraus abgeleitet ein Konzept zur Implementierung von Open Innovation bei Pharma-KMU zu entwickeln. Der Ausgangspunkt des Projektes war die Erkenntnis, dass die Life Sciences-Branche im Allgemeinen und die Pharmaindustrie im Besonderen durch eine steigende Komplexität der Innovationsprozesse und eine zunehmende Tendenz zu Kooperationen gekennzeichnet ist. Vor diesem Hintergrund eröffnet gerade der Open Innovation-Ansatz für die Pharmabranche neue Gestaltungs- und damit Wachstumsmöglichkeiten. Open Innovation – definiert als die planvolle Öffnung der Innovationsprozesse und die strategische Einbindung des Unternehmensumfelds – wird dabei als zentraler Erfolgsfaktor für die Innovationsfähigkeit beschrieben. N2 - The job title of innovation manager is a comparatively new phenomenon in innovation management. The field of responsibility spans the entire innovation process, from fundamental research, development and production, until the market launch. The competencies include technology, product, service and market orientation, and an innovation manager should have skills in both the strategic as well as the operational sphere. They direct the innovation process, cultivate both internal and external contacts and organise the communication of all persons involved. It is self-evident that these tasks – particularly in the pharmaceutical industry with its complex and long-term processes – present a considerable challenge for every innovation manager. With this in view, the following guidelines are directed primarily at innovation managers in medium sized pharmaceutical companies. The guidelines convey the knowledge and tools that enable the development of market and customer oriented products and services in the pharmaceutical industry from the very start. By means of images and descriptions it demonstrates which steps should be followed from idea generation, to project realization, until the market launch. The centerpiece is formed by the division of the innovation process into manageable, clearly defined phases, specifically tailored for the pharmaceutical industry. The guidelines particularly focus on the question of how customers, suppliers, competitors, etc. can be integrated into this process. This approach – termed open innovation in innovation management – when applied as a deliberate strategy, has the potential to reduce the costs of development and to raise the speed of passage of projects. KW - Innovation KW - Open Innovation KW - pharmazeutische Industrie KW - kleine und mittlere Unternehmen KW - KMU KW - Innovationsprozess KW - Innovation KW - open innovation KW - pharmaceutical industry KW - small and medium-sized enterprises KW - SME KW - innovation process Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus-50895 SN - 978-3-86956-103-5 PB - Universitätsverlag Potsdam CY - Potsdam ER -